MedTrace Logo

The Significance of Blood-tryptase and c-Kit Mutation in Insect Venom Immunotherapy

NCT02503800 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 159

Last updated 2019-08-20

No results posted yet for this study

Summary

The investigators wish to evaluate the association between tryptase values as well as c-Kit mutation and adverse effects in the course of immunotherapy. The investigators also intend to assess the effect of immunotherapy on tryptase levels.

Conditions

  • Hypersensitivity, Immediate
  • Insect Bites and Stings
  • Mastocytosis

Sponsors & Collaborators

  • Meir Medical Center

    lead OTHER

Principal Investigators

  • Alon Y Hershko, MD, PhD · Meir Medical Center

Eligibility

Min Age
4 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2019-02-15
Completion
2019-02-15

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02503800 on ClinicalTrials.gov